agilon health(US:AGL) Globenewswire·2026-03-31 12:15Core Viewpoint - Kaskela Law is investigating Agilon Health, Inc. on behalf of long-term investors due to allegations of securities fraud related to misleading statements about the company's medical costs [1][2]. Summary by Sections Investigation Details - A securities fraud complaint has been filed against Agilon for misleading investors about medical costs between April 15, 2021, and February 27, 2024 [2]. - The complaint alleges that Agilon and its senior executives made materially false statements, leading to a significant decline in stock value [3]. Financial Impact - Agilon's stock price fell approximately 85% during the relevant period, dropping from over $44.00 per share to less than $6.50 per share, a decline of over $38.00 per share [3]. Legal Concerns - The investigation focuses on whether Agilon's board of directors violated securities laws or breached fiduciary duties in connection with the alleged misconduct [4]. Shareholder Information - Current shareholders who acquired shares before May 1, 2023, are encouraged to contact Kaskela Law to discuss their legal rights and options regarding the investigation [5].